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e have previously observed that metabolic
oxidative stress–induced death domain–
associated protein (Daxx) trafficking is medi-
ated by the ASK1–SEK1–JNK1–HIPK1 signal transduction
pathway. The relocalized Daxx from the nucleus to the
cytoplasm during glucose deprivation participates in a
positive regulatory feedback loop by binding to apoptosis
signal–regulating kinase (ASK) 1. In this study, we report
that Akt1 is involved in a negative regulatory feedback
loop during glucose deprivation. Akt1 interacts with c-Jun
NH
 
2
 
-terminal kinase
 
 
 
(JNK)–interacting protein (JIP) 1, and
Akt1 catalytic activity is inhibited. The JNK2-mediated
phosphorylation of JIP1 results in the dissociation of Akt1
W
 
from JIP1 and subsequently restores Akt1 enzyme activity.
Concomitantly, Akt1 interacts with stress-activated protein
kinase/extracellular signal–regulated kinase (SEK) 1
(also known as MKK4) and inhibits SEK1 activity. Knock-
down of SEK1 leads to the inhibition of JNK activation,
JIP1–JNK2 binding, and the dissociation of Akt1 from
JIP1 during glucose deprivation. Knockdown of JIP1 also
leads to the inhibition of JNK activation, whereas the
knockdown of Akt1 promotes JNK activation during glu-
cose deprivation. Altogether, our data demonstrate that
Akt1 participates in a negative regulatory feedback loop
by interacting with the JIP1 scaffold protein.
 
Introduction
 
We have previously observed that glucose deprivation in-
creases the intracellular levels of hydroperoxide and glu-
tathione disulfide (Lee et al., 1998). The increased steady-state
levels of hydroperoxide and glutathione disulfide are sensed
through thioredoxin and glutaredoxin and subsequently acti-
vate the apoptosis signal–regulating kinase (ASK) 1–MEK–
MAPK–HIPK1 signal transduction pathway (Song et al.,
2002; Song and Lee, 2003a,b,c). The activated HIPK1 phos-
phorylates the death domain–associated protein (Daxx), lead-
ing to the relocalization of Daxx from the nucleus to the cyto-
plasm (Song and Lee, 2004). The translocated Daxx binds to
ASK1 and subsequently leads to ASK1 oligomerization (Song
and Lee, 2003a). The association of Daxx with ASK1 may
function as a positive feedback regulator to maintain/promote
ASK1–MEK–MAPK signal transduction through ASK1 oligo-
merization (Song and Lee, 2004). Unlike Daxx, CDC25A
phosphatase and mouse GST Mu 1-1 physically associate with
ASK1 and inhibit its oligomerization as well as its activity
(Cho et al., 2001; Zou et al., 2001).
Biological regulatory systems usually have switchlike
properties. Positive and negative feedback loops may produce
bistable systems under stress conditions. Bistability can result
from the combined effects of positive and negative regulators.
Thus, we hypothesized that glucose deprivation elicits both
positive and negative regulatory signaling pathways. As men-
tioned previously, Daxx-mediated ASK1 oligomerization may
act as a positive feedback loop for ASK1–MEK–MAPK signal
transduction by maintaining/promoting ASK1 activity. How-
ever, a fundamental question that remains unanswered is
how glucose deprivation–induced ASK1–MEK–MAPK signal
transduction can be negatively controlled. In this study, we
postulated that Akt1 acts as a negative regulator. A previous
study has shown that Akt interacts with ASK1 and negatively
regulates ASK1 by phosphorylating ASK1 on Ser-83 residue
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(Kim et al., 2001). Park et al. (2002) also observed that Akt
phosphorylates stress-activated protein kinase/extracellular sig-
nal–regulated kinase (SEK)1 on Ser-78 residue, resulting in the
inhibition of SEK1 enzyme activity. It is well known that the
Akt family of Ser/Thr-directed protein kinases (Akt1–3) are
important mediators of cell survival in response to growth fac-
tors, including insulin and insulin-like growth factor I (Bella-
cosa et al., 1998; Datta et al., 1999; Lawlor and Alessi, 2001;
Leinninger et al., 2004). Akt is activated by phosphoinositide-
dependent kinases 1 and 2 through phosphorylation at Thr-308
and Ser-473 residues (Alessi et al., 1997; Toker and Newton,
2000). A number of proapoptotic proteins have been identified
as direct Akt substrates, including Forkhead transcription fac-
tors, caspase-9, glycogen synthase kinase 3, and Bad (Cross et
al., 1995; Datta et al., 1997; del Peso et al., 1997; Cardone
et al., 1998; Pap and Cooper, 1998; Brunet et al., 1999; Kops et
al., 1999; Hetman et al., 2000). The proapoptotic function of
these molecules is suppressed upon phosphorylation by Akt.
Recently, Kim et al. (2002) reported an interaction between
Akt1 and c-Jun NH
 
2
 
-terminal kinase (JNK)–interacting pro-
tein (JIP) 1. The Akt1–JIP1 interaction is decreased concomi-
tantly with an increase in an association between JIP1 and
JNK (Kim et al., 2002). Based on that previous study, we hy-
pothesized that JIP1 negatively regulates Akt1 by means of
protein–protein interactions. The glucose deprivation–induced
dissociation of Akt1 from JIP1 leads to the restoration of Akt1
enzyme activity.
JIP1 is a scaffold protein that integrates both positive and
negative regulators of JNK. JIP1 assembles JNK, MKK7, and
mixed lineage protein kinase (MLK) proteins on different re-
gions of JIP1 and facilitates the JNK signaling pathway (Whit-
marsh et al., 1998, 2001). A JNK negative regulator, MAPK
phosphatase-7, also binds to JIP1 and inhibits JNK activation
by dephosphorylating JNK (Willoughby et al., 2003). A recent
Figure 1. Role of JIP1 in Akt activity in DU-145 cells. (A) Cells were exposed to glucose-free medium for various times (10–120 min). Cells were lysed,
and lysates were immunoprecipitated (IP) with anti–mouse Akt1 antibody. Immunoprecipitates were analyzed for the interaction of JIP1 with Akt1
(with anti-JIP1 antibody) and Akt1 catalytic activity in vitro using GST-Bad protein as a substrate (top). GST-Bad, phosphorylated GST-Bad, or Akt1 was de-
tected with anti-Bad, anti–phospho–Ser-136–Bad, or anti–rabbit Akt1 antibody, respectively. Cell lysates (bottom) were immunoblotted with anti-JIP1, anti-
phospho–Ser-473–Akt1, anti-Akt1, or antiactin antibody. (B) Immunoblot of JIP1 expression in control vector transfected (pSilencer) or pSilencer-siJIP1 stably
transfected (siJIP1#1–3) single cell clones from DU-145 cells. Lysates containing equal amounts of protein (20 g) were separated by SDS-PAGE and were
immunoblotted with anti-JIP1 antibody. (C) Control plasmid or pSilencer-siJIP1 stably transfected siJIP1#2 cells were lysed, and lysates were immunoprecip-
itated with anti–mouse Akt1 antibody. Akt1 catalytic activity in vitro was determined by using GST-Bad protein as a substrate (top). GST-Bad, phosphor-
ylated GST-Bad, or Akt1 was detected with anti-Bad, anti–phospho–Ser-136–Bad, or anti–rabbit Akt1 antibody, respectively. Cell lysates (bottom) were
immunoblotted with anti–phospho–Ser-473–Akt1, anti-JIP1, or antiactin antibody. (D) Cells were infected with adenoviral vector containing Flag-tagged
JIP1 cDNA (Ad.Flag-JIP1) at various multiplicity of infections (MOIs; 2–50). After 48 h of infection, cells were lysed, and lysates were immunoprecipitated
with anti–mouse Akt antibody. Immunoprecipitates were analyzed for Akt catalytic activity and JIP1 binding using immunoprecipitated Akt as described in
Fig. 1 A (top). The presence of JIP1 or actin in the lysates was verified by immunoblotting (bottom). (E and F) Cells were infected with Ad.EGFP and/or
Ad.Flag-JIP1 at various MOIs (10–200). After 48 h of infection, morphology was evaluated with a phase-contrast microscope (E), or cell lysates were
immunoblotted with anti-PARP, anti–caspase-9, anti-JIP1, or antiactin antibody (F).
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study revealed that the recruitment of JNK to JIP1 and the
phosphorylation of JIP1 by JNK are prerequisites for activation
of the JNK module (Nihalani et al., 2003). On the other hand,
JNK activity can be antagonized by Akt kinase activity in nu-
merous cellular systems (Levresse et al., 2000; Kim et al.,
2002; Barthwal et al., 2003; Aikin et al., 2004), and this cross
talk may underlie many of the prosurvival effects of Akt.
In this study, we have demonstrated that JIP1–Akt1 plays
an important role in the negative feedback loop during glucose
deprivation. Glucose deprivation–induced JNK2 activation
results in the phosphorylation of JIP1, which leads to the res-
toration of Akt1 activity by dissociating Akt1 from JIP1.
Subsequently, Akt1 inhibits the glucose deprivation–induced
ASK1–SEK1–JNK2 signal transduction pathway.
 
Results
 
Interaction between Akt1 and JIP1
 
A previous study has shown that Akt1 binds to JIP1, which is a
JNK pathway scaffold protein (Kim et al., 2002). We hypothe-
sized that JIP1 acts as a negative regulator of Akt1 and that
JIP1–Akt1 interaction results in the inhibition of Akt1 catalytic
activity. Metabolic oxidative stress may dissociate Akt1 from
JIP1, thereby restoring Akt1 enzyme activity. To test the hy-
pothesis, which was the first step in this study, we examined
whether endogenous JIP1 associates with endogenous Akt1 and
inhibits the enzymatic activity of Akt1 and whether metabolic
oxidative stress dissociates Akt1 from JIP1, thereby restoring
Akt1 enzyme activity. DU-145 cells were exposed to glucose-
free medium for various times (10–120 min). Cells were lysed
and immunoprecipitated with anti-Akt1 antibody followed by
immunoblotting with anti-JIP1 antibody, or Akt1 enzyme activ-
ity was measured by using an immune complex kinase assay.
Fig. 1 A shows that endogenous Akt1 interacted with endoge-
nous JIP1 (lane 2). However, Akt1 dissociated from JIP1 within
2 h during glucose deprivation (Fig. 1 A, lane 6). Fig. 1 A also
shows that Akt1 phosphorylated an Akt-specific substrate, Bad
(lane 6). These results suggest that Akt1 interacts with JIP1 and
that Akt1 catalytic activity is inhibited. The dissociation of Akt1
from JIP1 restores Akt1 enzyme activity, and the role of JIP1 in
Akt1 catalytic activity was further examined by the knockdown
of JIP1 expression. Unlike pSilencer control plasmid–trans-
fected cells, pSilencer–short interference (si)JIP1 stably trans-
fected siJIP1#2 cells contained a low level of JIP1 (Fig. 1 B)
and promoted Akt1 enzyme activity (Fig. 1 C). In contrast,
when JIP1 was overexpressed, more JIP1 associated with Akt1,
and the phosphorylation of Bad on Ser-136 was inhibited (Fig.
1 D, lanes 4–6). The inhibition of Bad phosphorylation was de-
pendent on the level of JIP1 expression (Fig. 1 D). These results
suggest that the interaction between Akt1 and JIP1 leads to the
inhibition of Akt1 activity. Most interesting, the overexpression
of JIP1 led to apoptosis, as shown by cell surface blebbing and
the formation of apoptotic bodies (Fig. 1 E). These observations
were consistent with poly (ADP-ribose) polymerase cleavage
(Fig. 1 F), which is the hallmark feature of apoptosis, and with
TUNEL assay (not depicted). Fig. 1 F also shows that pro-
Figure 2. Phosphorylation of Akt on Thr-308 and Ser-473 and its role in the association of Akt1 with JIP1. (A and B) DU-145 cells were infected with
adenoviral vector containing HA-tagged Akt1 (Ad.HA-Akt1) and/or Ad.Flag-JIP1 at an MOI of 10. After 48 h of infection, cells were lysed. Lysates were
immunoprecipitated with anti-HA antibody or anti-Flag antibody. Immunoprecipitated proteins and lysates were separated by SDS-PAGE and were im-
munoblotted with anti–phospho–Thr-308–Akt, anti–phospho–Ser-473–Akt, anti-Flag, anti-HA, or antiactin antibody. (C and D) DU-145 cells were trans-
fected with pHA-Akt1 (wild type), pHA-Akt1 (Thr-308A), pHA-Akt1 (Ser-473A), or pHA-Akt1 (Thr-308A  Ser-473A) plasmids and were infected with
Ad.Flag-JIP1 at an MOI of 10. After 48 h of incubation, cells were lysed. Cell lysates were immunoprecipitated with anti-HA antibody (C) or anti-Flag
antibody (D) and were immunoblotted with anti-Flag or anti-HA antibody (top). The presence of Flag-JIP1 or HA-Akt1 in the lysates was verified by immuno-
blotting with anti-Flag antibody or anti-HA antibody, respectively (bottom).
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caspase-9, the precursor form of caspase-9, was cleaved and ac-
tivated in JIP1-overexpressing cells. Apoptosis was dependent
on the level of JIP1 expression.
It is well known that Akt1 is activated by phosphoinosi-
tide-dependent kinase 1 through phosphorylation at the Thr-308
and Ser-473 residues (Alessi et al., 1997). Fig. 2 (A and B)
shows that Akt1 phosphorylated on Thr-308 and that Ser-473
binds to JIP1. To determine whether both residues play an
important role in the interaction between Akt1 and JIP1, site-
directed mutagenesis was used to create point mutations in one
or both residues, converting them to Ala residues (Thr-308A,
Ser-473A, and Thr-308A 
 

 
 Ser-473A). Fig. 2 (C and D)
clearly demonstrates that there is no difference between wild-
type Akt1 and mutant-type Akt1s in terms of binding to JIP1.
These results indicate that the phosphorylation of these resi-
dues is not essential for the binding of Akt1 to JIP1.
 
Effect of glucose deprivation on 
JIP1–Akt1 or JIP1–JNK1/2 interaction
 
To investigate whether metabolic oxidative stress dissociates
Akt1 from JIP1, DU-145 cells were infected with Ad.Flag-JIP1
and Ad.HA-Akt1. Cells were then exposed to glucose-free me-
dium for various times, and the interaction between the two mol-
ecules was examined by immunoprecipitation. Fig. 3 A shows
that Akt1 dissociated from JIP1 within 2 h during glucose dep-
rivation. We further examined whether our findings could be
generalized to other JIPs. Unlike JIP1, there was no interaction
between Akt1 and JIP3 (Fig. 3 B) or JIP2 (not depicted), regard-
less of the glucose concentration of the medium. Next, we exam-
ined the mechanism by which Akt1 dissociates from JIP1 during
glucose deprivation. We hypothesized that JNK is involved in
this process. As a first step, we investigated the interaction be-
tween JIP1 and JNK1/2 during glucose deprivation. Fig. 3 (C
and D) shows that the binding affinity of JNK2 to JIP1, but not
that of JNK1 to JIP1, was enhanced during glucose deprivation.
 
Phosphorylation of JIP1 on Thr-103 is 
responsible for the dissociation of Akt1 
from JIP1 during glucose deprivation
 
Previously, Nihalani et al. (2003) reported that JNK is involved
in the Thr-103 phosphorylation of JIP1, leading to the dissocia-
tion of dual zipper-bearing kinase (DLK) from JIP1. JNK re-
cruitment to JIP1 is related to the decreased affinity of JIP1 and
DLK (Nihalani et al., 2001). We postulated that metabolic oxi-
dative stress-induced JNK2 activation promotes the interaction
between JNK2 and JIP1 and leads to the phosphorylation of
JIP1 on Thr-103, thereby causing the dissociation of Akt1 from
JIP1. To examine this possibility, we used site-directed mutagen-
esis to create a point mutation at residue Thr-103 (Thr 
 
→ 
 
Ala) of
JIP1 and measured the effect on the dissociation of Akt1 from
JIP1 during glucose deprivation. Data from immune complex
kinase assays show that the glucose deprivation–induced phos-
phorylation of JIP1 by JNK2 was diminished in Thr-103A mu-
tant-type JIP1 (Fig. 4 A). Unlike wild-type JIP1, the inter-
action between Akt1 and Thr-103A mutant-type JIP1 was
maintained during glucose deprivation (Figs. 3 A and 4 B).
These data suggest that JNK2 binds to JIP1 and phosphory-
lates JIP1 on the Thr-103 residue during glucose deprivation.
The phosphorylation of JIP1 on Thr-103 leads to the dissocia-
tion of Akt1 from JIP1.
 
JNK2–JIP1 interaction and JNK2-
mediated phosphorylation of JIP1
 
Fleming et al. (2000) reported that phosphorylation of Thr-183
and Tyr-185 residues is required for the full activation of JNK2.
We hypothesized that phosphorylation of both residues during
glucose deprivation is essential for JNK2–JIP1 interaction and
the phosphorylation of JIP1. To test this possibility, Thr-183 and
Tyr-185 were replaced with Ala (Thr-183A) and phenylalanine
(Y185F), respectively. Fig. 5 A shows that glucose deprivation
increased the interaction between JIP1 and Thr-183A mutant-
Figure 3. Effect of glucose deprivation on
Akt1–JIP1/3 interaction or JIP1–JNK1/2 inter-
action. DU-145 cells were coinfected with
Ad.HA-Akt1 and Ad.Flag-JIP1 (A) or Flag-
tagged JIP3 (Ad.Flag-JIP3; B) at an MOI of
10. DU-145 cells were coinfected with
Ad.Flag-JIP1 and Ad.His-JNK1 (C) or Ad.HA-
JNK2 (D) at an MOI of 10. After 48 h of in-
fection, cells were exposed to glucose-free
medium for various times. (A and B) Cell ly-
sates were immunoprecipitated with anti-HA
antibody and were immunoblotted with anti-
Flag or anti-HA antibody (top). The presence
of Flag-JIP1, Flag-JIP3, phospho-Akt, or actin
in the lysates was verified by immunoblotting
(bottom). (C and D) Lysates were immunopre-
cipitated with anti-His/anti-HA antibody and
were immunoblotted with anti-Flag or anti-His/
anti-HA antibody (top). The presence of Flag-
JIP1 in the lysates was verified by immunoblot-
ting (bottom).
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type JNK2. Fig. 5 B also shows that Y185F mutant increased its
binding to JIP1 during glucose deprivation. However, the total
amount of JIP1 bound to the Y185F mutant-type JNK2 is much
less (Fig. 5 C). Data from densitometer tracings revealed that the
ratio of the relative intensity of JIP1/JNK2 of wild type is similar
to that of Thr-183A. However, the ratio of the relative intensity
of JIP1/JNK2 of Y185F is only 35% of the wild-type value.
These data suggest that the phosphorylation of Tyr-185 residue,
but not that of Thr-183 residue, facilitates the binding of JNK2
to JIP1. We further investigated whether the phosphorylation of
both JNK2 residues is required for the JNK2-mediated phosphor-
ylation of JIP1. Data from an immune complex kinase assay
shows that JIP1 was phosphorylated by only wild-type JNK2
during glucose deprivation, but not by either Thr-183A or
Y185F mutant-type JNK2 (Fig. 5 D). These results suggest that
phosphorylation of both the Thr-183 and Tyr-185 residues is
necessary for full activation of the JNK2 enzyme.
 
Role of SEK1 in JNK2 activation, JIP1–
JNK2 interaction, and Akt1–JIP1 binding
 
We previously observed that glucose deprivation activates the
ASK1–SEK1–JNK pathway (Song et al., 2002). To examine
whether glucose deprivation–activated SEK1 plays a role in the
interaction between JIP1 and JNK and in the dissociation of
Akt1 from JIP1, we attempted to silence SEK1 expression by us-
ing short hairpin RNAs. DU-145 cells were stably transfected
with either pSilencer control plasmid or pSilencer-siSEK1 vec-
tor. We selected several stable transfectants, as described in
Materials and methods. We chose three transfectant clones
(pSilencer, siSEK1#1, and siSEK1#2) for further studies (Fig.
6). Fig. 6 A shows that the expression of SEK1 was effectively
reduced in the siSEK1#2 transfectant. To examine the role of
SEK1 in the activation of JNK, pSilencer and siSEK1#2 trans-
fectants were exposed to glucose-free medium for various times
(Fig. 6 B) or for 60 min (Fig. 6 C). Fig. 6 (B and C) shows that
Figure 4. Phosphorylation of JIP1 on Thr-103
and its role in the dissociation of JIP1 from
Akt1 during glucose deprivation. (A) DU-145
cells were infected with Ad.HA-JNK2 at an
MOI of 10. After 48 h of infection, cells were
exposed to glucose-free medium for 1 h and
lysed. Cell lysates were immunoprecipitated
with anti-HA antibody. To examine which
amino acid residue of JIP1 can be phosphory-
lated by JNK2, 0.5 g GST-JIP1 (wild type) or
GST-JIP1–Thr-103A (mutant type) was incu-
bated with immunoprecipitated HA-JNK2 in ki-
nase buffer containing 100 Ci/ml -[32P]ATP
at 30C for 1 h. Phosphorylated proteins were
resolved by SDS-PAGE and were analyzed by
autoradiography. The presence of GST-JIP1 and HA-JNK2 in the kinase buffer was verified by immunoblotting with anti-JIP1 antibody and anti-HA anti-
body, respectively (top). The presence of HA-JNK2 in the lysates was verified by immunoblotting with anti-HA antibody (bottom). (B) DU-145 cells were
transfected with pFlag-JIP1–Thr-103A and infected with Ad.HA-Akt1. After 48 h of incubation, cells were exposed to glucose-free medium for various times
(1–4 h). Lysates were immunoprecipitated with anti-HA antibody and were immunoblotted with anti-Flag or anti-HA antibody (top). The presence of Flag-
JIP1–Thr-103A in the lysates was verified by immunoblotting with anti-Flag antibody (bottom).
Figure 5. Role of Thr-183 and Tyr-185 resi-
dues of JNK2 in glucose deprivation–induced
JNK2–JIP1 interaction or JIP1 phosphorylation.
DU-145 cells were coinfected with Ad.Flag-
JIP1 and adenoviral vector containing HA-
tagged wild-type JNK2 (Ad.HA-JNK2-wt),
Thr-183A mutant-type JNK2 (Ad.HA-JNK2–
Thr-183A), or Y185F mutant-type JNK2
(Ad.HA-JNK2-Y185F) at an MOI of 10. After
48 h of infection, cells were exposed to glu-
cose-free medium for various times (A and B)
or for 60 min (C and D) and were lysed. (A–C)
Lysates were immunoprecipitated with anti-
HA antibody and were immunoblotted with
anti-Flag or anti-HA antibody (top). The pres-
ence of Flag-JIP1 in the lysates was verified
by immunoblotting with anti-Flag antibody
(bottom). (D) Cell lysates were immunoprecip-
itated with anti-HA antibody. To examine
which types of JNK2 can phosphorylate JIP1,
0.5 g GST-JIP1 was incubated with immuno-
precipitated HA-JNK2 in kinase buffer con-
taining 100 Ci/ml -[32P]ATP at 30C for 1 h.
Phosphorylated proteins were resolved by
SDS-PAGE and were analyzed by autora-
diography. The presence of GST-JIP1 and HA-
JNK2 in the kinase buffer was verified by immunoblotting with anti-JIP1 antibody and anti-HA antibody, respectively (top). The presence of HA-JNK2 in
the lysates was verified by immunoblotting with anti-HA antibody (bottom).
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the glucose deprivation–induced activation of JNK and the phos-
phorylation of p46 and p54 was suppressed in the siSEK1#2
transfectant. Relatively less suppression was observed in the
siSEK1#1 transfectant (unpublished data). We further examined
whether the knockdown of SEK1 mRNA and protein suppresses
the interaction between JIP1 and JNK2 during glucose depriva-
tion. Fig. 7 A shows that the binding of JNK2 to JIP1 increased
during glucose deprivation in the pSilencer transfectant. How-
ever, this binding was markedly inhibited in the siSEK1#2
transfectant (Fig. 7, B and C). We also observed that glucose
deprivation–induced JNK activation, the dissociation of Akt1
from JIP1, and the restoration of Akt1 activity were delayed in
siSEK1#2 cells in comparison with pSilencer control vector–
transfected cells (Fig. 7, E and D). These data suggest that SEK1
plays an important role in JNK2 activation, the binding of JNK2
to JIP1, and the subsequent dissociation of Akt1 from JIP1.
 
Glucose deprivation–induced interaction 
between Akt1 and SEK1
 
A previous study has shown that Akt binds to SEK1 and subse-
quently inhibits SEK1 activity by phosphorylating mouse SEK1
on Ser-78 residue (Park et al., 2002). We postulated that the glu-
Figure 6. Glucose deprivation–induced JNK activation
in control plasmid (pSilencer) or pSilencer-siSEK1 stably
transfected DU-145 cells. (A) Immunoblot of SEK1 expres-
sion in control vector–transfected (pSilencer) or pSilencer-
siSEK1 stably transfected (siSEK1#1 and siSEK1#2) single
cell clones from DU-145 cells. Lysates containing equal
amounts of protein (20 g) were separated by SDS-PAGE
and were immunoblotted with anti-SEK1 antibody. Control,
untransfected cells. (B and C) Control plasmid or pSilencer-
siSEK1 stably transfected cells were exposed to glucose-
free medium for various times (10–120 min; B) or for 60
min (C). After incubating, cells were harvested, and West-
ern blot analysis was performed with anti–ACTIVE JNK,
anti-JNK2, or antiactin antibody as the loading control.
Figure 7. Role of SEK1 in the interaction between JIP1 and JNK2/Akt1 during glucose deprivation. Control plasmid (pSilencer) or pSilencer-siSEK1 stably
transfected (siSEK1#2) cells were coinfected with Ad.Flag-JIP1 and adenoviral vector containing HA-tagged JNK2 (Ad.HA-JNK2) or Ad.HA-Akt1 at an
MOI of 10. After 48 h of infection, cells were exposed to glucose-free medium for various times (A, B, D, and E) or for 60 min (C) and were lysed. Lysates
were immunoprecipitated with anti-HA antibody and were immunoblotted with anti-Flag or anti-HA antibody (A–E). Akt1 catalytic activity in vitro was de-
termined by using GST-Bad protein as a substrate (D and E). GST-Bad or phosphorylated GST-Bad was detected with anti-Bad or anti–phospho–Ser-136–
Bad antibody, respectively (top). Flag-JIP1, phosphorylated JNK, JNK2, or actin in the lysates was verified by immunoblotting with anti-Flag, anti–ACTIVE
JNK, anti-JNK2, or antiactin antibody, respectively (bottom).
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cose deprivation–induced dissociation of Akt1 from JIP1 leads
to the increased binding of Akt1 to SEK1. The interaction be-
tween Akt1 and SEK1 results in the inhibition of SEK1 enzyme
activity. To test this hypothesis, we first examined Akt1–SEK1
binding during glucose deprivation. Fig. 8 (A and B) shows that
binding of Akt1 to SEK1 gradually increased as a function of
time during glucose deprivation without changes in the intracel-
lular level of Akt1. We then investigated whether Akt1, which
dissociates from JIP1 during glucose deprivation, is the Akt1
that interacts with SEK1. Fig. 8 (C and D) shows that endoge-
nous Akt1 associated with endogenous SEK1 during glucose
deprivation for 2 h and phosphorylated human SEK1 on Ser-80
residue. As shown previously in Fig. 4 B, Akt1 binds to JIP1 be-
fore glucose deprivation. However, Akt1 does not dissociate
from the JIP1–Thr-103A mutant protein during glucose depriva-
tion. This indicates that JIP1 is responsible for the dissociation
of Akt1 from JIP1 during glucose deprivation. If it is true that
the dissociation of Akt1 from JIP1 causes an increase in the in-
teraction between Akt1 and SEK1, then that interaction should
likewise be diminished by the overexpression of JIP1–Thr-103A
mutant protein. Fig. 8 E shows that glucose deprivation–induced
Akt1–SEK1 interaction was suppressed by overexpressing mu-
tant-type JIP1–Thr-103A but not wild-type JIP1. These results
suggest that Akt1, which has been dissociated from JIP1, inter-
acts with SEK1. To examine whether the interaction between
Akt1 and SEK1 inhibits the catalytic activity of SEK1, cells
were coinfected with Ad.His-SEK1 and either Ad.HA-Akt1
wild type or Ad.HA-Akt1 mutant type (a dominant negative
form carrying a point mutation that ablates the kinase activity by
replacing Lys-179 residue with Met). Data from immune com-
plex kinase assays show that GST-JNK1 was phosphorylated by
His-SEK1 in cells that were deprived of glucose for 1 h (Fig.
8 F). This phosphorylation was reduced during 4 h of glucose
deprivation in Ad.HA-Akt1 (wild type)–infected cells, but not in
Ad.HA-Akt1–infected cells (Fig. 8 F). Altogether, these results
suggest that the enzymatic activity of SEK1 is inhibited by its
binding to Akt1 after several hours of glucose deprivation, re-
sulting from activation of the negative feedback loop.
Figure 8. Interaction between SEK1 and Akt1 and its role in SEK1 enzyme activity during glucose deprivation. DU-145 cells were coinfected with ade-
noviral vector containing His-tagged SEK1 (Ad.His-SEK1) and Ad.HA-Akt1 at an MOI of 10 (A, B, E, and F) and were transiently transfected with pFlag-
JIP1-wt (wild type) or pFlag-JIP1–Thr-103A (mutant type; E). (A and B) After 48 h of incubation, cells were exposed to glucose-free medium for various
times (1–4 h) and were lysed. Cell lysates were immunoprecipitated with anti-HA antibody (A) or anti-His antibody (B) and were immunoblotted with anti-
His or anti-HA antibody (top). The presence of His-SEK1, Akt, or phospho-Akt in the lysates was verified by immunoblotting (bottom). (C and D) DU-145
cells were exposed to glucose-free medium for 1 or 2 h and were lysed. Lysates were immunoprecipitated with anti–mouse Akt antibody. (C) Immunopre-
cipitates were analyzed for SEK1 binding with anti-SEK1 or anti–rabbit Akt antibody (top). The presence of SEK1 and Akt in the lysates was verified by
immunoblotting (bottom). (D) Immunoprecipitates were examined for the phosphorylation of SEK1 (Ser-80) by Akt. 0.5 g GST-SEK1 was incubated with
immunoprecipitated Akt in kinase buffer containing ATP at 30C for 1 h. Phosphorylated proteins were resolved by SDS-PAGE and were analyzed by
immunoblotting with anti–phospho-SEK1 (Ser-80) antibody. The presence of GST-SEK1 or Akt in the immunoprecipitate was verified by immunoblotting
with anti-SEK1 antibody or anti–rabbit Akt antibody, respectively (top). The presence of Akt, phospho-SEK1, or SEK1 in the lysates was verified by immu-
noblotting (bottom). (E) After 48 h of incubation, cells were exposed to glucose-free medium for 4 h and were lysed. Lysates were immunoprecipitated with
anti-His antibody and were immunoblotted with anti-HA or anti-His antibody (top). The presence of HA-Akt1, Flag-JIP1 wild type, or Flag-JIP1–Thr-103A in
the lysates was verified by immunoblotting (bottom). (F) DU-145 cells were coinfected with Ad.His-SEK1 and Ad.HA-Akt1 wild type (wt) or Ad.HA-Akt1
dominant negative mutant type (DN) at an MOI of 10. After 48 h of incubation, cells were exposed to glucose-free medium for 1 or 4 h and were lysed.
Lysates were immunoprecipitated with anti-His antibody. To examine the catalytic activity of SEK1, 0.5 g GST-JNK1 was incubated with immunoprecipi-
tated His-SEK1 in kinase buffer containing ATP at 30C for 1 h. Phosphorylated proteins were resolved by SDS-PAGE and were analyzed by immunoblotting
with anti–ACTIVE JNK antibody. The presence of GST-JNK1, His-SEK1, or HA-Akt1 in the immunoprecipitates was verified by immunoblotting (top).
The presence of HA-Akt1 (wt, DN) or His-SEK1 in the lysates was verified by immunoblotting (bottom).
 o
n
 July 1, 2014
jcb.rupress.org
D
ow
nloaded from
 
Published July 5, 2005
 JCB • VOLUME 170 • NUMBER 1 • 200568
 
Role of JIP1 in glucose deprivation–
induced JNK activation
 
To examine whether JIP1 plays an important role in JNK acti-
vation during glucose deprivation, pSilencer control plasmid–
transfected cells or pSilencer-siJIP1 stably transfected siJIP1#2
cells were exposed to glucose-free medium for various times
(Fig. 9 A) or for 60 min (Fig. 9 B). Fig. 9 shows that glucose
deprivation–induced JNK activation was suppressed in siJIP1#2
cells. Because JIP1 was a knockdown, but not a knockout, in
siJIP1#2 cells, basal levels of activated JNK was still observed.
The activation of JNK was restored by overexpressing JIP1 in
siJIP1#2 cells (Fig. 9 A, right).
 
Negative regulator role of Akt1 in glucose 
deprivation–induced JNK activation
 
Our studies have revealed that Akt1 acts as a negative regulator
for the ASK1–SEK1–JNK pathway during glucose deprivation.
To confirm our observations, cells were transfected with Akt1 or
mock siRNA. Fig. 10 A shows that the expression of Akt1 was
effectively inhibited by siAkt1. Glucose deprivation–induced
JNK activation (Fig. 10, B and C) and cytotoxicity (Fig. 10 D)
were promoted in siAkt1-transfected cells. To exclude off-target
effects of the siAkt construct, siAkt1-transfected cells were in-
fected with Ad.HA-Akt1. Fig. 10 (C and D) shows that the
overexpression of Akt1 in siAkt1-transfected cells suppressed
glucose deprivation–induced JNK activation and cytotoxicity.
These results suggest that Akt1 acts as a negative regulator for
the ASK1–SEK1–JNK pathway during glucose deprivation.
 
Discussion
 
The cellular functions of scaffolding proteins are to maintain
the specificity of signaling pathways and catalyze the activa-
tion of pathway components (Burack and Shaw, 2000). The JIP
family of scaffolding proteins associate with MAPK, MAPK
kinase, and MAPK kinase kinase and create a functional sig-
naling module to control the specificity of signal transduction
(Morrison and Davis, 2003). JIP1 scaffold facilitates JNK acti-
vation in an MLK-MKK7–dependent manner (Dickens et al.,
1997; Whitmarsh et al., 1998; Yasuda et al., 1999; Kelkar et
al., 2000). JIP3 mediates JNK signaling by interacting with
ASK1, MEKK1, and SEK1 (Ito et al., 1999; Matsuura et al.,
2002). JIP2 has been proposed to regulate p38 signaling mod-
ules (Schoorlemmer and Goldfarb, 2001; Matsuura et al.,
2002). Most interesting, JIP1 and 2 interact and form homo-
and heterooligomeric complexes with components of the JNK
signaling pathway and facilitate signal transduction (Yasuda et
al., 1999). However, our studies reveal that JIP1 also acts as a
negative regulator (Fig. 1). Data from immune complex kinase
assays show that JIP1 binds to Akt1 and inhibits Akt1 enzy-
matic activity (Fig. 1). Our observations somewhat contra-
dicted a recent report (Kim et al., 2003) that JIP1 activates
Akt1. We can only speculate that this discrepancy is a result of
differences in analytical methods (immunoblotting assay vs
immune complex kinase assay) because our data clearly dem-
onstrate that immunoblotting with phosphospecific Akt anti-
bodies does not truly reflect the catalytic activity of Akt. Data
from immunoblot assays illustrate that phosphorylated (active
form) Akt1 binds to JIP1; however, data from immune com-
Figure 9. Glucose deprivation–induced JNK activation in control plasmid
(pSilencer), pSilencer-siJIP1 stably transfected siJIP1#2, or Ad.Flag-JIP1–
infected siJIP1#2 cells. Cells were exposed to glucose-free medium for
various times (10–120 min; A) or for 60 min (B). Cell lysates were immuno-
blotted with anti–ACTIVE JNK, anti-JNK2, anti-JIP1, or antiactin antibody.
Figure 10. Role of Akt1 in glucose deprivation–induced
JNK activation and morphological damage. (A and B)
DU-145 cells were transfected with Akt1 siRNA or mock
siRNA and were incubated for 36 h. (A) Akt1 protein ex-
pression was assessed by immunoblotting with anti-Akt1
antibody. (B) Cells were exposed to glucose-free medium
for various times (10–120 min). Cell lysates were immu-
noblotted with anti–ACTIVE JNK, anti-JNK2, or antiactin
antibody. (C and D) DU-145 cells were transfected with
Akt1 or mock siRNA. After 24 of incubation, cells were
infected with Ad.EGFP or Ad.HA-Akt1 at an MOI of 10.
After 24 h of infection, cells were exposed to glucose-free
medium for 60 min (C) or for 24 h (D). (C) Cell lysates
were immunoblotted with anti–ACTIVE JNK, anti-JNK2,
anti-Akt1, or antiactin antibody. (D) Morphology was
evaluated with a phase-contrast microscope.
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plex kinase assays demonstrate that the enzymatic activity of
Akt1 is suppressed by binding with JIP1 (Figs. 1 and 2).
The present studies reveal that JNK2-dependent JIP1
phosphorylation on Thr-103 regulates JIP1–Akt1 binding
(Fig. 4). These results are consistent with a previous study that
demonstrated that the JNK-mediated phosphorylation of JIP1
on Thr-103 is essential for regulating the binding of DLK to
JIP1 (Nihalani et al., 2003). The dissociation of DLK from JIP1
results in DLK oligomerization, autophosphorylation, and, ulti-
mately, in module activation (Nihalani et al., 2003). However,
unlike DLK, phosphorylated Akt1 (active form) binds to JIP1
and is inactivated, whereas its dissociation from JIP1 results in
the restoration of activity (Figs. 1–3). Akt1 then binds to SEK1
and negatively regulates SEK1 by phosphorylating Ser-80 resi-
due (Park et al., 2002; Fig. 8). A previous study also revealed
that Akt negatively regulates ASK1 by phosphorylating Ser-83
residue (Kim et al., 2001) and preventing oligomerization (un-
published data). Altogether, the Akt-mediated inhibition of
SEK1 and/or ASK1 may act as a negative regulatory feedback
loop for the ASK1–MEK–MAPK signal transduction pathway.
Moreover, recent studies have demonstrated that during glu-
cose deprivation, Akt phosphorylates and activates ARK5,
which is a member of the AMP-activated protein kinase family
(Suzuki et al., 2003a, 2004a). Activated ARK5 phosphorylates
ataxia-telangiectasia mutated, a tumor suppressor, leading to
the activation of p53 by phosphorylation (Suzuki et al., 2003a).
The activation of ARK5, which is triggered by Akt during glu-
cose deprivation, suppresses caspase activation and prevents
cell death (Suzuki et al., 2003b, 2004b). It is possible that Akt-
activated ARK5 is involved in the negative regulatory feed-
back loop for the ASK1–MEK–MAPK signal transduction
pathway. This possibility needs to be investigated.
It was well known that HSP90 binds to Akt, and the inhi-
bition of this Akt–HSP90 interaction by HSP90 inhibitors leads
to the dephosphorylation and inactivation of Akt (Basso et al.,
2002; Sato et al., 2000). Protein phosphatase 2A or protein
phosphatase 1 may play an important role in the regulation of
Akt dephosphorylation (Sato et al., 2000; Xu et al., 2003). In
this study, we did not observe any significant reduction of the
level of Akt1 phosphorylation during glucose deprivation (Fig.
3 A). Thus, HSP90 is not likely involved in the regulatory feed-
back loop for the ASK1–MEK–MAPK signal transduction
pathway during glucose deprivation.
Previous studies have shown that JNK is activated by dual
phosphorylation on the tripeptide motif Thr-X-Tyr, where X is
any amino acid (Payne et al., 1991; Lawler et al., 1998). Two
MAPK kinases, MKK4 and MKK7, synergistically activate
JNK (Lawler et al., 1998; Ito et al., 1999; Matsuura et al., 2002;
Kishimoto et al., 2003). MKK4 prefers Tyr-185 residue, and
MKK7 prefers Thr-183 residue (Lawler et al., 1998; Fleming et
al., 2000). Our data demonstrate that the full activation of JNK
requires the phosphorylation of both residues (Fig. 5 D). How-
ever, the phosphorylation of JNK2 on Tyr-185 is a prerequisite
for the recruitment of JNK2 to JIP1 (Fig. 5). Most interesting,
the knockdown of SEK1 (MKK4) mRNA and protein by siRNA
for SEK1 during glucose deprivation leads to the inhibition of
JNK activation, JIP1–JNK2 binding, and the dissociation of
Akt1 from JIP1 (Figs. 6 and 7). These results suggest that
SEK1-mediated JNK2 phosphorylation is necessary for the res-
toration of Akt1 enzyme activity. As mentioned in the Introduc-
tion, JIP1 specifically scaffolds JNK, MKK7, and members of
the MLK family. In contrast, the ASK1–SEK1–JNK-signaling
module preferentially interacts with JIP3 (Matsuura et al.,
2002). Altogether, we postulate that two scaffolding proteins,
JIP1 and 3, have a cross talk that leads to the regulation of the
ASK1–SEK1–JNK signal during glucose deprivation. Glucose
deprivation rapidly increases the interaction between ASK1 and
JIP3, and the consequently activated ASK1 phosphorylates
SEK1 on the Thr-261 residue. The activated SEK1 dissociates
from JIP3 and phosphorylates JNK2 on the Tyr-185 residue.
Phosphorylated JNK2 binds to JIP1, and the phosphorylation of
the JNK2 Thr-183 residue occurs. Activated JNK2 phosphory-
lates JIP1 on the Thr-103 residue and leads to the dissociation of
Akt1 from JIP1. Dissociated Akt1 binds to SEK1 and ASK1 and
inhibits their enzyme activity by phosphorylating SEK1 on the
Ser-80 residue and ASK1 on the Ser-83 residue. Although JIP3
and 1 are structurally distinct, we believe that cross talk takes
place between these two scaffolding proteins. Obviously, fur-
ther studies are necessary to understand the role of scaffolding
proteins in the glucose deprivation–induced negative feedback
loop. Our model will provide a framework for future studies.
 
Materials and methods
 
Cell culture
 
Human prostate adenocarcinoma DU-145 cells were cultured in DME with
10% FBS (HyClone) and 26 mM sodium bicarbonate for monolayer cell
culture. The cells were maintained in a humidified atmosphere containing
5% CO
 
2
 
 and air at 37
 

 
C.
 
Reagents and antibodies
 
Polyclonal anti-SEK1, anti–phospho–Thr-308–Akt, anti–phospho–Ser-473–
Akt, anti-Akt, anti-Bad, and anti–phospho–Ser-136–Bad were purchased
from Cell Signaling, and anti–ACTIVE JNK was purchased from Promega.
mAbs were purchased from the following companies: anti-JIP1 from Santa
Cruz Biotechnology, Inc.; antiactin from ICN; anti-HA (clone 3F10) from
Roche Diagnostics; anti-Flag (clone M2; mouse) from Sigma-Aldrich; and
anti-His (penta-His; mouse) from QIAGEN.
 
Site-directed mutagenesis
 
The QuickChange Site-Directed Mutagenesis Kit (Stratagene) was used to
make point mutations in Akt1, JNK2, or JIP1 protein. One Thr residue in
Akt1 (Thr-308 Akt1) was replaced with Ala (Thr-308A Akt1). Sense primer
(5
 

 
-GGTGCCACTATGAAGGCATTCTGCGGAACGC-3
 

 
) and antisense
oligonucleotides (5
 

 
-GCGTTCCGCAGAATGCCTTCATAGTGGCACC-3
 

 
)
were used for site-directed mutagenesis. For the mutation of another phos-
phorylation site of Akt1, Ser-473 residue was changed to Ala. Sense (5
 

 
-
TCCCCCAGTTCGCCTACTCAGCCAGTG-3
 

 
) and antisense primer oligo-
nucleotides (5
 

 
-CACTGGCTGAGTAGGCGAACTGGGGGA-3
 

 
) were
used for site-directed mutagenesis. One Thr residue in JNK2 (183 JNK2)
was replaced with Ala (Thr-183A). Sense (5
 

 
-CCAACTTTATGATGGCTC-
CCTATGTGGTG-3
 

 
) and antisense primer oligonucleotides (5
 

 
-CACCA-
CATAGGGAGCCATCATAAAGTTGG-3
 

 
) were used for site-directed mu-
tagenesis. One Tyr residue in JNK2 (185 JNK2) was replaced with Phe
(Y185F). Sense (5
 

 
-CTTTATGATGACTCCCTTTGTGGTGACACGGTAC-3
 

 
)
and antisense primer oligonucleotides (5
 

 
-GTACCGTGTCACCACAAA-
GGGAGTCATCATAAAG-3
 

 
) were used for site-directed mutagenesis.
One Thr residue in JIP1 (103 JIP1) was replaced with Ala (Thr-103A).
Sense primer (5
 

 
-GGCAGGTGACGCTCCGGGCGCCG-3
 

 
) and antisense
oligonucleotides (5
 

 
-CGGCGCCCGGAGCGTCACCTGCC-3
 

 
) were used
for site-directed mutagenesis. PCR reaction was prepared by adding 5 
 

 
l
of 10
 

 
 reaction buffer, 20 ng of double-stranded (ds) DNA template (pAd-
lox-HA-JNK2), 125 ng of each sense primer, 125 ng of each antisense
primer, 1 
 

 
l deoxyribonucleotide triphosphate mix, double-distilled water
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to a final volume of 50 
 

 
l, and 1 
 

 
l Pfu Turbo DNA polymerase (2.5
U/
 

 
l). PCR was performed with 14 cycles (95
 

 
C for 30 s; 58
 

 
C for 1 min;
68
 

 
C for 7 min) with initial incubation at 95
 

 
C for 30 s. After temperature
cycling, the reaction was placed on ice for 2 min to cool the reaction. After
PCR, 1 
 

 
l DpnI restriction enzyme (10 U/
 

 
l) was added directly to each
amplification reaction and incubated at 37
 

 
C for 1 h to digest the parental
supercoiled dsDNA. The DpnI-treated dsDNA was transformed into Epicur-
ian Coli XL1-blue supercompetent cells. Colonies were selected, and each
plasmid (pAdlox-HA-JNK2, pAdlox-HA-Akt1, and pAdlox-JIP1) was se-
quenced using primer (5
 

 
-GGATGCTAACTTATGTCAGG-3
 

 
 for JNK2; 5
 

 
-
CGAGAGCGCGTGTTCTCCGAG-3
 

 
 for Akt1 308 and 473; and 5
 

 
-CAT-
GACATCAGCCTGGAGGAG-3
 

 
 for JIP1) to confirm mutation.
 
RNA interference by siRNA of SEK1 or Akt1
 
To stably express siRNA for long-term knockdown, pSilencer 2.1-U6 hygro
vector (Ambion) was used for clonal cell lines. The inserts for hairpin
siRNA into pSilencer were prepared by annealing two oligonucleotides.
For human SEK1 siRNA, the top strand sequence was 5
 

 
-GATCCA-
CGCAAAGCACTGAAGTTGTTCAAGAGACAACTTCAGTGCTTTGCGTT-
TTTTTGGAAA-3
 

 
, and the bottom strand sequence was 5
 

 
-AGCTTTTC-
CAAAAAAACGCAAAGCACTGAAGTTGTCTCTTGAACAACTTCAGTGC-
TTTGCGTG-3
 

 
. The annealed insert was cloned into pSilencer 2.1-U6 hy-
gro digested with BamH I and HindIII. The correct structure of pSilencer
2.1-U6 hygro–SEK1 was confirmed by nucleotide sequencing. The result-
ant plasmid, p
 
S
 
ilencer-SEK1, was transfected into DU-145 cells, and 250
 

 
g/ml hygromycin B–resistant cell clones were isolated. The interference
of SEK1 protein expression was confirmed by immunoblot using anti-SEK1
antibody.
To down-regulate Akt1, Akt1 siRNA (Santa Cruz Biotechnology,
Inc.) was used. Cells were transfected with Akt1 siRNA and were incu-
bated for 36 h. The interference of Akt1 protein expression was confirmed
by immunoblotting using anti-Akt1 antibody (Upstate Biotechnology).
 
In vivo binding of Akt1 and JIP1 (or JIP3)
 
To examine the interaction between Akt1 and JIP1/3, DU-145 cells in
100-mm culture plates were coinfected with the adenovirus of HA-tagged
Akt1 (Ad.HA-Akt1) and Flag-tagged JIP1 (Ad.Flag-JIP1) or Flag-tagged
JIP3 (Ad.Flag-JIP3). For immunoprecipitation, cells were lysed in buffer
containing 150 mM NaCl, 20 mM Tris-HCl, pH 7.5, 10 mM EDTA, 1%
Triton X-100, 1% deoxycholate, 1 mM PMSF, 80 
 
M aprotinin, and 2
mM leupeptin, and the lysates were incubated with 0.5 g of rat anti-HA
antibody for 2 h. After the addition of protein G agarose, the lysates were
incubated for an additional 2 h. The beads were washed three times with
the lysis buffer, separated by SDS-PAGE, and immunoblotted with mouse
anti-Flag or rat anti-HA antibodies. The proteins were detected with the en-
hanced chemiluminescence reaction.
Shuttle vector construction
Adlox-HA-Akt1 was produced by inserting a HindIII–EcoRI fragment from
pCMV6- HA-Akt1 into HindIII–EcoRI-cut pAdlox shuttle vector. pCMV5-
Flag-JIP1 was provided by R. Davis (University of Massachusetts Medical
School, Amherst, MA). pAdlox-Flag-JIP1 having Flag tagged at their NH2-
terminal and restriction enzyme recognition sites at the flanking sides (5,
HindIII; 3, XbaI) was produced by PCR using pcMV5-Flag-JIP1 as a tem-
plate. The sense primer was 5-TAATAAGCTTGCGGAGCGAGAGAGCG-
GCCTG-3, and the antisense primer was 5-GCCGTCTAGACTACTC-
CAAGTAGATATCTTC-3. PCR was performed for 30 cycles (94C for 30 s,
55C for 30 s, and 68C for 2 min 30 s) with an initial incubation at
94C for 1 min. For JIP1 (or JIP1–Thr-103A) protein purification, a PCR
product of mouse JIP1 having restriction enzyme sites at the flanking sides
(5, EcoRI; 3, SalI) was produced using pcDNA3-T7-JIP1 (pAdlox-JIP1 Thr-
103A) as a template. The sense primer was 5-TAATGAATTCGCGGAGC-
GAGAGAGCGGCCTG-3, and the antisense primer was 5-GCCAG-
TCGACCTACTCCAAGTAGATATCTTCTG-3. pGEX-4T-1-JIP1 (or JIP1–
Thr-103A) was made by inserting an EcoRI–SalI fragment from JIP1 (or
JIP1 Thr-103A) PCR product into EcoRI–SalI-cut pGEX-4T-1 (Amersham
Biosciences). pGEX-4T-1-JIP1 (or JIP1–Thr-103A) was transformed into
JM109, and JIP1 (JIP1–Thr-103A) expression was confirmed by anti-JIP1
(Cell Signaling). GST-JIP1 (or JIP1–Thr-103A) was purified by using glu-
tathione Sepharose 4B column (Amersham Biosciences). pcDNA3-Flag-
JIP3 was provided by K. Yoshioka (Kanazawa University, Kanazawa,
Japan). pAdlox-Flag-JIP3 having Flag tagged at their NH2-terminal and re-
striction enzyme recognition sites at the flanking sides (5, SphI; 3, AccI)
was produced by PCR using pcDNA3-Flag-JIP3 as a template. The sense
primer was 5-CTGCGCATGCTGATGGACTACAAAGACGATGACGA-
CAAGCT-3, and the antisense primer was 5-CATCTAGTCGACTCACT-
CAGGGGTGTAGGACACCTGCC-3. pcDNA3.1-His C-SEK1 was made
by inserting the BamHI fragment from pEBG-SEK1. Adlox-His-SEK1 was
made by inserting the SpeI–XbaI fragment from pcDNA3.1-His C-SEK1
into SpeI–XbaI-cut pAdlox shuttle vector. pLNCX-HA p54 JNK2  were
provided by L.E. Heasley (University of Colorado Health Sciences Center,
Denver, CO). pLNCX-HA p54 JNK2  were digested with HindIII–ClaI,
and their fragments were subcloned into HindIII–AccI-digested pAdlox.
Adenoviral vector construction
All recombinant adenoviruses were constructed by using the Cre-lox recom-
bination system (Hardy et al., 1997). The selective cell line CRE8 has a
-actin–based expression cassette driving a Cre recombinase gene with an
NH2-terminal nuclear localization signal stably integrated into 293 cells.
Transfections were done by using Lipofectamine Reagent (Invitrogen). 5 
105 cells were split into a 6-well plate 1 d before transfection. For the pro-
duction of recombinant adenovirus, 2 g SfiI-digested Adlox/HA-Akt1, Adlox/
Flag-JIP1, Adlox/Flag-JIP3, His-SEK1, HA-JNK2, and HA-JNK2 (Thr-183A and
Y185F) and 2 g of 	5 viral genomic DNA were cotransfected into CRE8
cells. The recombinant adenoviruses were generated by intermolecular ho-
mologous recombination between the shuttle vector and 	5 viral DNA.
A new virus has an intact packaging site and carries a recombinant gene.
Plaques were harvested, analyzed, and purified. The insertion of each com-
ponent to adenovirus was confirmed by Western blot analysis after the infec-
tion of corresponding recombinant adenovirus into DU-145 cells.
Immune complex kinase assay
For the immune complex kinase assay, DU-145 cells were infected with
Ad.HA-Akt1/Ad.Flag-JIP1 at a multiplicity of infection (MOI) of 10. After
48 h of infection, cells were lysed in a buffer solution containing 20 mM
Tris-HCl, pH 7.5, 150 mM NaCl, 5 mM EGTA, 10 mM NaF, 1% Triton
X-100, 0.5% deoxycholate, 2 mM DTT, 1 mM sodium orthovanadate, 1 mM
PMSF, and protein inhibitor cocktail solution (Sigma-Aldrich). Cell extracts
were clarified by centrifugation, and the supernatants were immunopre-
cipitated with rat anti-HA antibody (3F10; Roche Diagnostics) or mouse
anti-Flag antibody (Sigma-Aldrich) and protein G agarose (Santa Cruz
Biotechnology, Inc.). The beads were washed twice with a solution con-
taining 150 mM NaCl, 20 mM Tris-HCl, pH 7.5, 5 mM EGTA, 2 mM
DTT, 1 mM sodium orthovanadate, 1 mM PMSF, and protein inhibitor
cocktail solution, were washed once with the kinase buffer solution, and
were subjected to kinase assays. To examine whether the JIP1-bound
Akt1has a catalytic activity, GST-tagged fusion Bad protein (Santa Cruz
Biotechnology, Inc.) was used as a substrate of Akt1. 1 g Bad was incu-
bated with immunoprecipitated HA-Akt1 or Flag-JIP1–HA-Akt1 complex in
kinase buffer containing 20 mM Tris-HCl, pH 7.5, 20 mM MgCl2, 1 mM
sodium orthovanadate, 2 mM DTT, and 20 M ATP at 30C for 1 h. Fi-
nally, the reaction was stopped by adding 2 Laemmli buffer. Phosphory-
lated proteins were resolved by SDS-PAGE and were analyzed by immu-
noblotting by using anti–phospho-Bad (Ser-136) antibody (Cell Signaling).
For in vitro kinase assay of JIP1 phosphorylation by JNK2, DU-145 cells
were infected with various types of Ad.HA-JNK2 (wild type, Thr-183A,
and Y185F) at an MOI of 10. After 48 h of infection, cells were incubated
in glucose-free medium for 1 h and were lysed in a buffer solution contain-
ing 20 mM Tris-HCl, pH 7.5, 150 mM NaCl, 5 mM EGTA, 10 mM NaF,
1% Triton X-100, 0.5% deoxycholate, 0.1% SDS, 2 mM DTT, 1 mM so-
dium orthovanadate, 1 mM PMSF, and protein inhibitor cocktail solution
(Sigma-Aldrich). Cell extracts were clarified by centrifugation, and the
supernatants were immunoprecipitated with rat anti-HA antibody and
protein G agarose. The beads were washed three times with the same
solution as the beads above, were washed once with the kinase buffer so-
lution, and were subjected to kinase assays. 0.5 g GST-JIP1 or GST-JIP1
(Thr-103A) was incubated with various immunoprecipitated types of HA-
JNK2 in kinase buffer containing 20 mM Tris-HCl, pH 7.5, 20 mM MgCl2,
1 mM sodium orthovanadate, 2 mM DTT, 20 M ATP, and 100 Ci/ml
-[32P]ATP at 30C for 1 h. Finally, the reaction was stopped by adding
2 Laemmli buffer. Phosphorylated proteins were resolved by SDS-PAGE
and were analyzed by autoradiography.
Immunoblot analysis
Cell lysates were subjected to electrophoresis on 10% polyacrylamide
gels containing SDS under reducing conditions, and the proteins in the
gels were transferred onto a polyvinylidine difluoride membrane. The
membranes were incubated with 7% (wt/vol) skim milk in PBST (PBS con-
taining 0.1% [vol/vol] Tween 20) and were reacted with primary antibod-
ies. After washing three times with PBST, the membranes were incubated
with HRP-conjugated anti-IgG. The proteins were then detected with the
ECL reagent.
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